Book Description

Section 1: Cardiology 1. Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease 2. System of Care for Patients with ST-segment Elevation Myocardial Infarction in India: The Tamil Nadu-ST-segment Elevation Myocardial Infarction Program 3. Predictors of Death in Contemporary Adult Patients with Eisenmenger Syndrome: A Multicenter Study 4. Midterm Results of Tetralogy of Fallot with Absent Pulmonary Valve 5. Meta-analysis of the Impact of Intervention versus Symptom-driven Management in Asymptomatic Severe Aortic Stenosis 6. Prevalence and Clinical Manifestations of Primary Aldosteronism Encountered in Primary Care Practice 7. Heart Failure with Preserved, Borderline, and Reduced Ejection Fraction--5-year Outcomes 8. Angiotensin-converting Enzyme Inhibitors and Angiotensin Receptor Blockers in High Vascular Risk 9. Trends in Use of High-intensity Statin Therapy after Myocardial Infarction, 2011 to 2014 10. Trend in Prevalence of Coronary Artery Disease and Risk Factors Over Two Decades in Rural Punjab 11. Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation 12. Implant and Midterm Outcomes of the Subcutaneous Implantable Cardioverter-Defibrillator Registry: The EFFORTLESS Study 13. Maternal and Fetal Outcomes of Anticoagulation in Pregnant Women with Mechanical Heart Valves 14. Diuretic Treatment in Heart Failure 15. Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease 16. Oxygen Therapy in Suspected Myocardial Infarction 17. Optimal Timing of an Invasive Strategy in Patients with Non-ST Elevation Acute Coronary Syndrome: A Meta-analysis of Randomized Trials 18. Fruits, Vegetables, and Legume Intake and Cardiovascular Disease and Deaths in 18 Countries (PURE): A Prospective Cohort Study 19. Global Mortality Variations in Patients with Heart Failure: Results from the International Congestive Heart Failure (INTER-CHF) Prospective Cohort Study 20. 3-Year Clinical Outcomes with Everolimus-eluting Bioresorbable Coronary Scaffolds--The ABSORB III Trial Section 2: Chest and Critical Care 1. The Effects of Atorvastatin on Inflammatory Responses and Mortality in Septic Shock: A Single-center, Randomized Controlled Trial 2. Prevalence and Etiological Profile of Chronic Obstructive Pulmonary Disease in Nonsmokers 3. Pulmonary Rehabilitation in Patients with Interstitial Lung Diseases in an Outpatient Setting: A Randomized Controlled Trial 4. Correlation of Cutaneous Sensitivity and Cytokine Response in Children with Asthma 5. Clinical Profile and Treatment Outcome of Drug-resistant Tuberculosis Patients of Western Maharashtra, India 6. Prevalence of Aspergillus Hypersensitivity and Allergic Bronchopulmonary Aspergillosis in Patients with Bronchial Asthma at a Tertiary Care Center in North India 7. The Effect of Diabetes Control Status on Treatment Response in Pulmonary Tuberculosis: A Prospective Study 8. Efficacy and Safety of Glycopyrrolate/Formoterol Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Patients With COPD 9. Use of Mycophenolate Mofetil or Azathioprine for the Management of Chronic Hypersensitivity Pneumonitis 10. Early Computed Tomography Modifications Following Bronchial Thermoplasty in Patients with Severe Asthma 11. Nintedanib in Patients with Idiopathic Pulmonary Fibrosis and Preserved Lung Volume 12. Severe and Difficult-to-treat Asthma in Adults 13. Acute Respiratory Distress Syndrome 14. Evaluation of a Rapid Molecular Drug-susceptibility Test for Tuberculosis 15. Effect of Azithromycin on Asthma Exacerbations and Quality of Life in Adults with Persistent Uncontrolled Asthma (AMAZES): A Randomised, Double-blind, Placebo-controlled Trial 16. Mepolizumab for Eosinophilic Chron